Full Spectrum Cannabis Extracts Help Against Neurodegenerative Diseases Posted by Admin, Posted on 09 February 2024

Will Full Spectrum Cannabis Extracts Help Against Neurodegenerative Diseases?

Full-spectrum cannabis extracts are becoming increasingly popular for a wide range of use cases. Research on the efficacy of these extracts against neurodegenerative diseases continues to receive more attention. Let’s see what these extracts have to offer, how to get the best from this medication, and other vital details.

Getting correct information about these extracts can be valuable to ease symptoms linked to diverse neurodegenerative diseases, guarantee better health outcomes and improved quality of life without hassle.

What are Neurodegenerative Diseases?

Neurodegenerative diseases are health conditions that occur because of deteriorating neurons in the human central nervous system (CNS). These diseases lead to several debilitating symptoms and can cause a rapid decline motor and cognitive functions in humans.

How Can Full-Spectrum Cannabis Extracts Help Against Neurodegenerative Diseases?

With neuroprotective properties

The cannabis plant is loaded with hundreds of potential chemical compounds, but the popular duo – tetrahydrocannabinol (THC) and cannabidiol (CBD). Evidence on the psychoactive properties of THC is quite common, but many studies seem to neglect the neuroprotective benefits the compound provides.

Studies like Pagano, Navarro, and Coppola (2022) have revealed that THC possesses anti-inflammatory, antispasmodic, and neuroprotective properties. These properties can be effective towards the treatment of neurodegenerative disorders.

Through reduction of associated symptoms

A systematic review of medical marijuana’s efficiency in select neurological disorders was conducted by Koppell et. al., (2014). Participants in this study received oral cannabis extracts in one group, with others ingesting oral THC formulations and CBD sprays. It was discovered at the end of this study that persons who received oral cannabis extracts showed significant self-improvements within one year.

The study also focused on pain management for persons who experience neuropathic pain as symptoms. In all the positive results recorded, side effects from using such extracts was at a measly 1%.

Another study by Wade et. al., (2006)reported a decrease in dosage of cannabis products across two clinical trials. Researchers discovered no withdrawal symptoms after administration of cannabis extracts to reduce the effect of neurodegenerative diseases. The findings suggest that cannabis extracts can be potent to help patients overcome issues caused by neurodegenerative diseases without lingering side effects or addiction.

Modulation of endocannabinoid activity

Studies like Pacher and Kunos (2013) suggest that modulation of endocannabinoid activity can help deliver effective therapies against neurodegenerative, gastrointestinal, and other health issues. The endocannabinoid system (ECS) has received extensive attention in studies like Whiting et. al., (2015) to suggest that cannabis extracts can be effective against a host of neurodegenerative diseases in humans.

How to Ensure Full-Spectrum Cannabis Extracts are Effective against Neurodegenerative Diseases

Accurate microdosing

Evidence from studies like Koppell et. al. (2014)reveals that accurate microdosing is crucial to the efficacy of full-spectrum cannabis extracts against neurodegenerative disorders. Proper microdosing of these extracts can help deliver improved outcomes against these disorders towards better health management and improved quality of life.

Seek expert advice

It is essential to consult an experienced medical practitioner for guidance about medical cannabis extracts to treat neurodegenerative diseases. Guidance from an experienced health practitioner with enough knowledge about cannabis extracts can be crucial to achieve better results while receiving medication against these disorders.

Use quality products

The growing acceptance for medical cannabis products attracts the development of substandard varieties with their natural effects watered-down or synthesized. It is essential to avoid knockoff cannabis extracts and use products made from natural strains that possess superior properties.

Using the best cannabis extracts guarantee better access to improve care against neurodegenerative diseases and other health issues.

Get the Best High-Quality Cannabis Extracts for Better Support against Neurodegenerative Diseases

Premium-grade full-spectrum cannabis extracts possess superior properties that can be of great benefit for persons dealing with diverse neurological diseases.

Products from a trusted brand like Cannabryl is essential to deliver effective support against health issues that can cause debilitating neurological decline. Cannabryl is a subsidiary of Indogenix Biosciences and deals with the development of effective medical remedies made from natural plant extracts.

Using potent products made from superior cannabis strains gives Cannabryl a greater potency over generic variants. Every full-spectrum extract produced by Cannabryl comes from the rare, premium-grade Himalayan native strain known for its potent properties and significant support for health benefits.

Conclusion

High-quality cannabis extracts can provide support against neurodegenerative diseases. Diverse use cases of the natural extract make it a suitable option to provide palliative care, help manage pain, and improve the overall quality of life patients experience. Seek the best extracts from a top brand with proven results against different health issues and achieve total wellbeing with ease.

References

Atakan, Z. (2012) Cannabis, A Complex Plant: Different Compounds and Different Effects on Individuals. Ther. Adv. Psychopharm. 2(6):241–254. doi: 10.1177/2045125312457586

Koppell, B. S., Brust, J. C., Fife, T., Bronstein, J., Youssof, S., Gronseth, G., (2014). Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurological Disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 82 (17), 1556–1563

Pagano, C, Navarra, G, Coppola, L, (2022) Cannabinoids: Therapeutic Use in Clinical Practice. Int J Mol Sci. 23(6):3344. doi: 10.3390/ijms23063344.

Parker, A. L. (2017) Cannabinoids and the Brain. Cambridge, MA. The Massachusetts Institute of Technology (MIT) Press. ISBN 9780262035798

Raz, N., Eyal, M. A., and Davidson, E. (2022) Optimal Treatment with Cannabis Extracts Formulations Is Gained via Knowledge of Their Terpene Content and via Enrichment with Specifically Selected Monoterpenes and Monoterpenoids. Molecules 2022, 27(20), 6920; https://doi.org/10.3390/molecules27206920

Sarne, Y, Asaf, F, and Fishbein, M, (2011). The Dual Neuroprotective-Neurotoxic Profile of Cannabinoid Drugs. Brit. J. Pharmacol. 2011;163(7):1391–1401. doi: 10.1111/j.1476-5381.2011.01280.x.

Uziel, A., Gelfand, A., Amsalem, K., Berman, P., Lewitus, M. G., Meiri, D., and Lewitus, Y. D. (2020) Full-Spectrum Cannabis Extract Microdepots Support Controlled Release of Multiple Phytocannabinoids for Extended Therapeutic Effect. CS Appl. Mater. Interfaces 2020, 12, 21, 23707–23716

Wade, D. T., Makela, P. M., House, H., Bateman, C., and Robson, P. 2006. Long-Term Use of a Cannabis-Based Medicine in the Treatment of Spasticity and Other Symptoms in Multiple Sclerosis. Multiple Sclerosis 12 (5), 639–645.

Whiting, P. F., Wolff, R. F., Deshpande, S. Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., Schmidlkofer, S., Westwood, M., Kleijnen, J. (2015) Cannabinoids for Medical Use: A Systematic Review and Meta-Analysis, JAMA. 2015;313(24):2456-2473. doi:10.1001/jama.2015.6358

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Our content is founded upon scientific studies, ensuring reliability. Prior to considering cannabis or cannabinoids for symptom or illness management, it is strongly advised to seek guidance from a specialized medical professional. Commercial utilization of our content is strictly prohibited. Alteration, adaptation, or translation of our content requires prior consent. Downloading and utilizing our content is permitted solely for educational purposes, with appropriate accreditation. Publication of our content necessitates explicit authorization. CANNABRYL does not endorse the opinions expressed by its collaborators and writers.

Leave a message

All Comments

    RELATED ARTICLE

    View More